Professor
NICU Medical Director, University of Washington Medical Center
Neonatology

Dr. Mayock’s basic research interests include evaluation of the effects of fetal and neonatal drug (alcohol, morphine) exposure on fetal, neonatal and adult cerebrovascular function. Dr. Mayock’s clinical research interests include evaluation of therapies that potentially may alter the development of Bronchopulmonary Dysplasia such as inhaled nitric oxide and late surfactant treatments. In collaboration with Drs. Juul and Gleason, he is evaluating whether high dose erythropoietin treatment has neuroprotective effects in preterm and term infants.